Management of insomnia: Treatments and mechanisms

British Journal of Psychiatry

Volumn 191, Issue 3, 2007, Pages 195-197

  Wilson, Sue ^a   Nutt, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CHLORPROMAZINE; CLOMETHIAZOLE; DIPHENHYDRAMINE; ESZOPICLONE; HISTAMINE H2 RECEPTOR; HYDROXYZINE; MELATONIN; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; PROMETHAZINE; QUETIAPINE; RAMELTEON; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZALEPLON; ZOLPIDEM; ZOPICLONE;

BEHAVIOR THERAPY; COGNITIVE THERAPY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; INSOMNIA; LOW DRUG DOSE; PSYCHOTHERAPY; REBOUND; SHORT SURVEY;

BEHAVIOR THERAPY; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; HYPNOTICS AND SEDATIVES; PSYCHOTROPIC DRUGS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 34548765427     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.036301     Document Type: Short Survey

References (18)

1. Allain, H., tue-Ferrer, D., Polard, E., et al (2005) Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs and Aging, 22, 749-765.
2. Buscemi, N., Vandermeer, B., Hooton, N., et al (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. Journal of General Internal Medicine, 20, 1151-1158.
3. Buscemi, N., Vandermeer, B., Hooton, N., et al (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ, 332, 385-393.
4. Dundar, Y., Dodd, S., Strobl, J., et al (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology, 19, 305-322.
5. Erman, M., Seiden, D., Zammit, G., et al (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Medicine, 7, 17-24.
6. Espie, C. A., MacMahon, K. M., Kelly, H. L., et al (2007) Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep, 30, 574-584.
7. Green, A., Hicks, J. A., Weeks, R., et al (2005) A cognitive-behavioural group intervention for people with chronic insomnia: an initial evaluation. British Journal of Occupational Therapy, 68, 518-522.
8. Hicks, J. A., Argyropoulos, S. V., Rich, A. S., et al (2002) Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. British Journal of Psychiatry, 180, 528-535.
9. Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., et al (2004) Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Archives of Internal Medicine, 164, 1888-1896.
10. Jansson, M. & Linton, S. J. (2005) Cognitive-behavioral group therapy as an early intervention for insomnia: a randomized controlled trial. Journal of Occupational Rehabilitation, 15, 177-190.
11. Kaynak, H., Kaynak, D., Gozukirmizi, E., et al (2004) The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Medicine, 5, 15-20.
12. Krystal, A. D., Walsh, J. K., Laska, E., et al (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep, 26, 793-799.
13. Morin, C. M. & Espie, C. A. (2003) Insomnia: A Clinician's Guide to Assessment and Treatment. Kluwer.
14. Morin, C. M., Bootzin, R. R., Buysse, D. J., et al (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep, 29, 1398-1414.
15. Nutt, D. J. (2005) NICE: The National Institute of Clinical Excellence - or Eccentricity? Reflections on the Z-drugs as hypnotics. Journal of Psychopharmacology, 19, 125-127.
16. Roth, T., Walsh, J. K., Krystal, A., et al (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Medicine, 6, 487-495.
17. Thase, M. E., Kupfer, D. J., Buysse, D. J., et al (1995) Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression. I. Comparison during acute depressive states. Biological Psychiatry, 38, 506-515.
18. Winokur, A., DeMartinis, N. A., III, McNally, D. P., et al (2003) Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. Journal of Clinical Psychiatry, 64, 1224-1229.